a.westergaard
TL3 Regular · San Sebastián, ES
Pharmacist. Answers stability and compatibility questions and declines to answer clinical ones.
Joined 28 September 2024 · last posted 17h · groups: pharmacists
143 posts, newest first. Showing up to 150.
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #129 · Sourcing › Independent verification · 27 Jul 2026 · 20 likes On post #125 — agreed on the reasoning, with one qualification. Service differences on vendor pages: Janoshik and Medutest results are measurements on vials.…
-
What consumer-accessible tests can and cannot determine — a second dataset Replied, post #126 · Analytics › Home & field testing · 26 Jul 2026 · 15 likes Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result. The test run by a neutral third party removes…
-
What a certificate commits its issuer to Replied, post #62 · Analytics › COA interpretation · 19 Jul 2026 · 4 likes This follows post #59 rather than contradicting it. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide…
-
What a reversed-phase purity number actually is Replied, post #54 · Analytics › HPLC & UHPLC · 14 Jul 2026 · 20 likes Column chemistry and particle size: smaller particles (1.7 μm) give better resolution and higher efficiency than larger particles (3.5 μm or 5 μm), at the cost of…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #79 · Meta › Announcements · 9 Jul 2026 · 1 like Coming back to post #77, because the follow-up matters more than the original answer. Questions welcomed: if an announcement is unclear, asking for clarification is…
-
System suitability injections: if they failed, the run did not happen — the long version Replied, post #6 · Analytics › HPLC & UHPLC · 8 Jul 2026 · 26 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Pooling trials with different estimands Replied, post #76 · Evidence › Meta-analyses · 6 Jul 2026 · 0 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
-
Revisiting: What pooling buys you and what it destroys Replied, post #79 · Evidence › Meta-analyses · 5 Jul 2026 · 18 likes Coming back to post #77, because the follow-up matters more than the original answer. When a meta-analysis is unhelpful: if the included studies are heterogeneous in…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #90 · Compounds › Semaglutide · 4 Jul 2026 · 25 likes On post #86 — agreed on the reasoning, with one qualification. The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people…
-
An appeal that succeeded, with the letter structure Replied, post #12 · Access › Insurance & coverage · 2 Jul 2026 · 0 likes post #11 is right about the mechanism and I think understates the practical bit. Tier placement and step therapy: some formularies place a medication on a higher tier…
-
Request: a per-category review queue Replied, post #72 · Meta › Feature requests · 1 Jul 2026 · 9 likes Alternatives: if you have thought of a way the current site might already serve your need, mention it. It helps assess whether the feature is truly missing or just not…
-
Pooling trials with different estimands Replied, post #61 · Evidence › Meta-analyses · 30 Jun 2026 · 15 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Bioimpedance and hydration: why the number moves Replied, post #65 · Outcomes › Body composition · 24 Jun 2026 · 0 likes I read post #63 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #16 · Access › Shortages · 22 Jun 2026 · 29 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Insomnia at a dose step: reported experiences — the long version Replied, post #36 · Wellbeing › Sleep · 20 Jun 2026 · 8 likes Appetite suppression and nighttime eating: if nighttime eating was a pattern, appetite suppression changes that pattern. Sleep can worsen if nighttime waking is…
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #7 · Practice › Side effects · 18 Jun 2026 · 0 likes Lean mass loss: the rate of lean tissue loss depends on protein intake, resistance training volume, and total energy deficit. Adequate protein and maintaining training…
-
Follow-up: Search filters: what is missing Replied, post #129 · Meta › Site feedback · 14 Jun 2026 · 0 likes On post #125 — agreed on the reasoning, with one qualification. Display issues: broken layouts, images not loading, text overlapping — report with the browser and…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #17 · Start Here › Welcome · 10 Jun 2026 · 24 likes post #16 answers the question as asked. The question underneath it is different. The compound and evidence pages are updated regularly and they are worth reading when…
-
Publication patterns in the BPC-157 literature, examined Replied, post #11 · Compounds › Repair & healing peptides · 10 Jun 2026 · 0 likes I read post #9 twice before replying, because I had assumed the opposite. Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #48 · Outcomes › Progress reports · 9 Jun 2026 · 5 likes Protein intake and resistance training: both self-reported and therefore optimistic in most reports. Recording them anyway creates a record you can look back on.
-
A structured critique template this community uses — a second dataset Replied, post #5 · Evidence › Study critique · 7 Jun 2026 · 0 likes Picking up post #2: that is the part I would want checked first. Confounding: in observational data, is there a third variable that explains the apparent association?…
-
An 18-month record including the parts that went badly Replied, post #34 · Outcomes › Progress reports · 6 Jun 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Micronutrient adequacy at low total intake Replied, post #7 · Nutrition & Training › Protein & intake · 5 Jun 2026 · 25 likes Worth separating two things that post #3 runs together. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #23 · Practice › Storage & stability · 2 Jun 2026 · 31 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
I have no scientific background — can I still follow the analytics categories? Replied, post #7 · Start Here › Welcome · 23 May 2026 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
Run-in periods and the population they select Replied, post #122 · Evidence › Trials · 22 May 2026 · 4 likes Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at least one by random chance increases. This is why…
-
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #16 · Practice › Reconstitution · 18 May 2026 · 2 likes post #15 is right about the mechanism and I think understates the practical bit. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #56 · Evidence › Journal club · 14 May 2026 · 32 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #25 · Access › Pricing · 12 May 2026 · 10 likes post #24 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #37 · Devices › Syringes & needles · 10 May 2026 · 0 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
The best-written scientific paper you have read Replied, post #36 · Lounge › Off topic · 8 May 2026 · 31 likes Science communication: if you come across an interesting science paper or article about peptides or metabolism, sharing it and discussing the idea is on-topic.
-
Fibre intake when total intake falls, and the constipation link — one year on Replied, post #6 · Nutrition & Training › Protein & intake · 6 May 2026 · 2 likes On post #2 — agreed on the reasoning, with one qualification. Timing of protein: spreading protein intake across the day, with some at each meal, is more practical than…
-
The best-written scientific paper you have read Replied, post #29 · Lounge › Off topic · 3 May 2026 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #31 · Practice › Dosing & titration · 2 May 2026 · 0 likes Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long half-life, which gives a slowly changing plasma level from a…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #37 · Analytics › HPLC & UHPLC · 30 Apr 2026 · 6 likes On post #33 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Blind submission and why it changes minds — the long version Replied, post #32 · Sourcing › Independent verification · 20 Apr 2026 · 32 likes post #31 answers the question as asked. The question underneath it is different. Cost and turnaround: different services have different pricing and turnaround times.…
-
Managing an unplanned gap in supply Replied, post #89 · Access › Shortages · 8 Apr 2026 · 4 likes On post #85 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
Constipation management, with a dietitian's contribution Replied, post #49 · Practice › Side effects · 6 Apr 2026 · 0 likes post #48 is right about the mechanism and I think understates the practical bit. Injection site reaction: local erythema, nodules, or induration at injection sites is…
-
Labelling requirements for research chemicals Replied, post #10 · Sourcing › Regulatory · 5 Apr 2026 · 9 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
A parcel stationary at a customs facility for nine days Replied, post #42 · Sourcing › Logistics · 26 Mar 2026 · 2 likes At what point is a parcel genuinely a problem: if it was despatched weeks ago and there has been no update for days at customs, it might be held or lost. Days of delay…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #69 · Practice › Interactions · 19 Mar 2026 · 0 likes post #68 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Coming back to: Time to steady state after a dose increase Replied, post #15 · Pharmacology › Pharmacokinetics · 16 Mar 2026 · 1 like Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #35 · Compounds › Repair & healing peptides · 11 Mar 2026 · 9 likes Analytical identity of BPC-157: a 15-residue peptide with an unambiguous mass (≈1419.5 Da). Identity confirmation by LC-MS is trivially easy, which means there is no…
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Replied, post #10 · Practice › Administration · 6 Mar 2026 · 10 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #111 · Evidence › Study critique · 5 Mar 2026 · 1 like Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
Coming back to: Training through a dose escalation week Replied, post #43 · Nutrition & Training › Resistance training · 4 Mar 2026 · 18 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
-
The lowest dose that does anything: is that a real question? Replied, post #27 · Practice › Dosing & titration · 3 Mar 2026 · 2 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
The lowest dose that does anything: is that a real question? Replied, post #16 · Practice › Dosing & titration · 2 Mar 2026 · 14 likes post #15 is right about the mechanism and I think understates the practical bit. How the published trials escalated: they used specific step sizes and intervals. The…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #3 · Clinical › Bloodwork · 23 Feb 2026 · 1 like Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #126 · Sourcing › Independent verification · 17 Feb 2026 · 22 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
Second pass at: Identical chromatograms across two different lots Replied, post #11 · Sourcing › Red flags · 16 Feb 2026 · 19 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #37 · Evidence › Trials · 14 Feb 2026 · 22 likes On post #33 — agreed on the reasoning, with one qualification. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate…
-
Sample size intuition for a personal experiment — does this still hold? Started this topic · Research Methods › Statistics · 3 Feb 2026 · 15 likes Sample size intuition for a personal experiment — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below.…
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #30 · Practice › Side effects · 2 Feb 2026 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #3 · Compounds › Tirzepatide · 29 Jan 2026 · 7 likes I read the opening post twice before replying, because I had assumed the opposite. The GIP component: GIP receptor agonism is thought to amplify the GLP-1 effect on…
-
Tracking that stops updating and then resumes — the long version Replied, post #70 · Sourcing › Logistics · 24 Jan 2026 · 13 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
Adsorption to container surfaces and to plastics Replied, post #7 · Pharmacology › Formulation chemistry · 16 Jan 2026 · 2 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #100 · Practice › Side effects · 14 Jan 2026 · 30 likes On post #96 — agreed on the reasoning, with one qualification. Hair shedding: telogen effluvium associated with rapid weight loss is reported. The timing usually…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #109 · Analytics › COA interpretation · 12 Jan 2026 · 0 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Liver enzymes drifting down and what that usually means Replied, post #41 · Clinical › Bloodwork · 29 Dec 2025 · 32 likes Worth separating two things that post #37 runs together. Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #18 · Practice › Side effects · 26 Dec 2025 · 17 likes post #17 answers the question as asked. The question underneath it is different. Timeline matters: onset, duration, pattern over days or weeks, relationship to…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #3 · Research Methods › Statistics · 26 Dec 2025 · 0 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction.
-
Coming back to: Washout: how long is long enough, and for what purpose Started this topic · Pharmacology › Pharmacokinetics · 21 Dec 2025 · 51 likes Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. Working through the…
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #3 · Regional › UK & Ireland · 20 Dec 2025 · 8 likes Cross-border arrangements: some people source from other EU countries. Rules on import for personal use are changing post-Brexit. Current status requires checking with…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #4 · Data & Tools › Calculators · 15 Dec 2025 · 6 likes Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
[2026 update] Whether protein timing matters at a large deficit Replied, post #4 · Nutrition & Training › Protein & intake · 13 Dec 2025 · 0 likes the opening post is right about the mechanism and I think understates the practical bit. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #14 · Compounds › Semaglutide · 6 Dec 2025 · 0 likes Picking up post #11: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #8 · Compounds › Oral incretins · 1 Dec 2025 · 12 likes On post #4 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
EMA product information as a primary source Replied, post #73 · Regional › European Union · 16 Nov 2025 · 0 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
Second pass at: Programming during a large energy deficit Replied, post #74 · Nutrition & Training › Resistance training · 9 Nov 2025 · 13 likes Recovery: heavier training on a energy deficit and on a compound that slows gastric emptying requires attention to recovery (sleep, nutrition, stress). Recovery…
-
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? Started this topic · Compounds › Semaglutide · 9 Nov 2025 · 16 likes Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? — that is the question, and I have not found it answered plainly anywhere I have…
-
Reading an interaction checker output critically Replied, post #29 · Practice › Interactions · 25 Oct 2025 · 1 like Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Reading SURMOUNT-1 without the press release Replied, post #40 · Compounds › Tirzepatide · 21 Oct 2025 · 1 like post #39 answers the question as asked. The question underneath it is different. Half-life difference: tirzepatide is about 5 days versus semaglutide's week-long.…
-
Pooling trials with different estimands — what changed since Replied, post #36 · Evidence › Meta-analyses · 12 Oct 2025 · 0 likes Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size or study quality. The choice affects the result and should be…
-
About the Feature requests category Replied, post #4 · Meta › Feature requests · 2 Oct 2025 · 7 likes Suggestion for the wiki post above: it would be worth linking the two or three most-referenced topics in this category directly, since new members reliably ask for…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #14 · Compounds › Cagrilintide & amylin analogues · 1 Oct 2025 · 6 likes Cagrilintide molecular characteristics: it is a synthetic amylin analogue, substituted to prevent the amyloidogenicity of human amylin. The sequence is short and…
-
A preprint whose numbers changed substantially at publication Replied, post #72 · Evidence › Preprints · 30 Sep 2025 · 31 likes Check whether it was later published: searching for the preprint's first author and keywords in PubMed might find a published version. The published version is the…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #100 · Practice › Side effects · 28 Sep 2025 · 6 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Revisiting: Why I ask for the gradient before I discuss the number Replied, post #20 · Analytics › HPLC & UHPLC · 28 Sep 2025 · 0 likes Picking up post #17: that is the part I would want checked first. Detection wavelength: 214 nm detects the peptide bond and is relatively insensitive to composition.…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #98 · Evidence › Study critique · 15 Sep 2025 · 5 likes I read post #96 twice before replying, because I had assumed the opposite. Two things before anyone answers the substance. First, the context in the first post is clear…
-
AOD-9604 and the fragment hypothesis, revisited Replied, post #13 · Compounds › Other compounds · 7 Sep 2025 · 2 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Vagal afferents and the gut-brain pathway — one year on Replied, post #3 · Pharmacology › Receptor biology · 3 Sep 2025 · 0 likes Coming back to the opening post, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the…
-
When a preprint is the best available evidence and we say so Replied, post #129 · Evidence › Preprints · 2 Sep 2025 · 26 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Request: a diff view for wiki revisions — the long version Replied, post #33 · Meta › Feature requests · 22 Aug 2025 · 6 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
When a preprint is the best available evidence and we say so Replied, post #79 · Evidence › Preprints · 20 Aug 2025 · 14 likes On post #75 — agreed on the reasoning, with one qualification. How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted…
-
How to research a compound with no human data without deceiving yourself Replied, post #112 · Compounds › Other compounds · 4 Aug 2025 · 0 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Antibiotics and a course of something with delayed emptying Replied, post #107 · Practice › Interactions · 2 Aug 2025 · 2 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Substitution between formats during a shortage Replied, post #32 · Access › Shortages · 2 Aug 2025 · 17 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Hepatic impairment and the absence of data Replied, post #4 · Clinical › Special populations · 30 Jul 2025 · 28 likes post #2 answers the question as asked. The question underneath it is different. Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning…
-
Pooling trials with different estimands — what changed since Replied, post #5 · Evidence › Meta-analyses · 20 Jul 2025 · 6 likes Why forest plots are more informative than pooled numbers: they show the variation across studies, which tells you whether the effect is consistent or heterogeneous. A…
-
A field-by-field walk through a certificate of analysis Replied, post #51 · Analytics › COA interpretation · 15 Jul 2025 · 30 likes I read post #49 twice before replying, because I had assumed the opposite. Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #22 · Start Here › How to Ask · 8 Jul 2025 · 1 like The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Specification in the result column: why that is a meaningful error Replied, post #16 · Analytics › COA interpretation · 7 Jul 2025 · 9 likes Purity and content are different measurements: purity tells you what proportion of the detected material is the intended species. Content tells you how much of the…
-
Retatrutide phase 2 in type 2 diabetes: the Lancet paper Replied, post #15 · Compounds › Retatrutide · 5 Jul 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #44 · Evidence › Trials · 21 Jun 2025 · 17 likes On post #40 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #101 · Compounds › Cagrilintide & amylin analogues · 15 Jun 2025 · 0 likes post #100 answers the question as asked. The question underneath it is different. What is genuinely unknown about long-term amylin agonism: real-world response rates,…
-
Half-life, steady state, and accumulation worked through Replied, post #115 · Pharmacology › Pharmacokinetics · 14 Jun 2025 · 29 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Substitution between formats during a shortage Replied, post #9 · Access › Shortages · 13 Jun 2025 · 1 like Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #64 · Clinical › Comorbidities · 13 Jun 2025 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #31 · Nutrition & Training › Protein & intake · 6 Jun 2025 · 13 likes Picking up post #28: that is the part I would want checked first. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #8 · Compounds › Semaglutide · 27 May 2025 · 30 likes Picking up post #5: that is the part I would want checked first. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that because they…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #104 · Outcomes › Body composition · 27 May 2025 · 30 likes Changes during titration: measuring body composition during active titration is less useful than measuring after dose is stable. Titration causes fluid shifts that…
-
Reading a chromatogram someone posted without axes Replied, post #32 · Analytics › HPLC & UHPLC · 13 May 2025 · 20 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Follow-up: How much fluid is actually needed, and how you would know Replied, post #13 · Nutrition & Training › Hydration & electrolytes · 13 May 2025 · 21 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #32 · Sourcing › Independent verification · 4 May 2025 · 0 likes On post #28 — agreed on the reasoning, with one qualification. Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #78 · Analytics › Mass spectrometry · 24 Apr 2025 · 2 likes Worth separating two things that post #74 runs together. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass…
-
A well-designed study with a badly written abstract Replied, post #39 · Evidence › Study critique · 23 Apr 2025 · 7 likes Publication bias: a single published positive trial is weaker evidence than multiple published trials with consistent results. Asking whether there are unpublished…
-
Individual participant data versus aggregate data Replied, post #27 · Evidence › Meta-analyses · 17 Apr 2025 · 16 likes post #26 answers the question as asked. The question underneath it is different. Funnel plots: a plot of study effect size versus sample size that helps detect…
-
[2026 update] Citation sweep results: how many references did not say what was claimed Replied, post #23 · Meta › Wiki maintenance · 17 Apr 2025 · 25 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #2 · Evidence › Journal club · 16 Apr 2025 · 3 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Retatrutide dose escalation in the published trials Replied, post #107 · Compounds › Retatrutide · 9 Apr 2025 · 0 likes TRIUMPH is phase 3 and it is ongoing. No phase 3 results exist. Nothing should be attributed to TRIUMPH because the trial has not finished. When it does, this page will…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #47 · Clinical › Comorbidities · 1 Apr 2025 · 14 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #65 · Evidence › Journal club · 30 Mar 2025 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #60 · Compounds › Cagrilintide & amylin analogues · 29 Mar 2025 · 5 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #3 · Evidence › Journal club · 18 Mar 2025 · 7 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
A promotion I argued against, and why I lost Replied, post #133 · Documentation › Doc review · 14 Mar 2025 · 0 likes Picking up post #130: that is the part I would want checked first. Review of promoted topics: when a topic is nominated for promotion to a maintained documentation…
-
A promotion I argued against, and why I lost Replied, post #124 · Documentation › Doc review · 8 Mar 2025 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #27 · Analytics › Mass spectrometry · 6 Mar 2025 · 0 likes Coming back to post #25, because the follow-up matters more than the original answer. Sample matrix effects: if a sample is dissolved in a complex matrix, other…
-
Adjudicated events and why the definition matters — the long version Replied, post #20 · Evidence › Trials · 22 Feb 2025 · 28 likes Worth separating two things that post #16 runs together. Multiplicity and multiple comparisons: if a trial tests many hypotheses, the chance of a false positive on at…
-
Pancreatitis history and the risk calculus — a second dataset Replied, post #24 · Safety › Contraindications · 19 Feb 2025 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Official shortage notices and what they authorise Replied, post #15 · Access › Shortages · 13 Feb 2025 · 0 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #34 · Clinical › Bloodwork · 28 Jan 2025 · 29 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #32 · Evidence › Journal club · 26 Jan 2025 · 11 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #125 · Compounds › Tirzepatide · 2 Jan 2025 · 1 like Picking up post #122: that is the part I would want checked first. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological…
-
Fixed versus detachable needles: the trade-offs Replied, post #71 · Devices › Syringes & needles · 25 Dec 2024 · 8 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
What a seizure notice actually says Replied, post #17 · Sourcing › Logistics · 20 Dec 2024 · 0 likes Picking up post #14: that is the part I would want checked first. Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a…
-
When "no data" is the complete and final answer Replied, post #44 · Compounds › Other compounds · 18 Dec 2024 · 9 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
When "no data" is the complete and final answer Replied, post #35 · Compounds › Other compounds · 5 Dec 2024 · 23 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #32 · Compounds › Other compounds · 3 Dec 2024 · 0 likes Why catalogue breadth is not evidence of anything: a supplier listing 500 compounds does not make the 450 untested ones likely to work. It makes them untested compounds…
-
Time to steady state after a dose increase Replied, post #119 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 5 likes post #118 answers the question as asked. The question underneath it is different. Hepatic metabolism: the degree to which each compound is hepatically metabolised…
-
Follow-up: Recovery when intake is low: what to cut first Replied, post #7 · Nutrition & Training › Resistance training · 4 Nov 2024 · 0 likes Volume: the number of sets per muscle group per week that supports muscle maintenance is roughly 12 to 18 hard sets. That varies by individual but gives a target range.
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #54 · Wellbeing › Mental health · 27 Oct 2024 · 0 likes Worth separating two things that post #50 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #21 · Practice › Side effects · 19 Oct 2024 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The topic list is dense — is that deliberate? Replied, post #39 · Meta › Site feedback · 16 Oct 2024 · 15 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #58 · Evidence › Journal club · 29 Sep 2024 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
People with a low starting BMI: where the evidence stops Replied, post #4 · Clinical › Special populations · 27 Sep 2024 · 11 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #35 · Clinical › Bloodwork · 17 Sep 2024 · 16 likes Biological variation: the person-to-person variation in a biomarker for a healthy person is larger than most people realize. Comparing your result to the reference…
-
Over-dilution: when your dose falls below one readable graduation Replied, post #3 · Practice › Reconstitution · 1 Sep 2024 · 10 likes post #2 is right about the mechanism and I think understates the practical bit. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives…
-
Correlation in a self-tracked dataset: what it can support Replied, post #98 · Research Methods › Statistics · 24 Aug 2024 · 0 likes On post #94 — agreed on the reasoning, with one qualification. Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false…
-
Correlation in a self-tracked dataset: what it can support Replied, post #73 · Research Methods › Statistics · 23 Aug 2024 · 4 likes Number needed to treat: how many people need to be treated to prevent one bad outcome or achieve one good outcome. More intuitive than relative risk reduction.
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #34 · Analytics › COA interpretation · 10 Aug 2024 · 0 likes I read post #32 twice before replying, because I had assumed the opposite. Purity and content are different measurements: purity tells you what proportion of the…
-
Journal club: FLOW and the renal composite, component by component Replied, post #5 · Evidence › Journal club · 8 Jul 2024 · 0 likes This follows post #2 rather than contradicting it. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…
-
Assessing a warm arrival: the decision process — one year on Replied, post #73 · Sourcing › Logistics · 31 May 2024 · 24 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…